The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males
Clinical trial NCT04470908 · COMPLETED
Trial details
- NCT number
- NCT04470908
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2020-11-10
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.